The findings of this study highlight the fact that neither OA administration nor DM (T1D or T2D) appear to inhibit the ability of HPP or HPS to induce microvessel formations in vitro, despite the significantly reduced VEGF concentrations in HPP and PF-4 levels in HPS, compared to non-OA controls. Here, VEGFA is linked to type 2 diabetes mellitus.